Neonatal pulse oximetry screening for critical congenital heart disease

Critical congenital heart disease (CCHD) includes structural heart defects that can cause severe circulatory compromise when the ductus arteriosus begins to close after birth. Some affected newborns appear well during the first hours of life, making a careful physical examination alone insufficient. Pulse oximetry provides a fast, noninvasive way to identify babies who may need urgent cardiac assessment before deterioration occurs.

The screening measures oxygen saturation in the right hand and either foot. Differences between these readings, persistently low saturation, or a pattern that does not meet the screening threshold can indicate a possible cardiac problem. The test does not diagnose a specific defect; it identifies infants who require further evaluation.

This approach belongs within a broader perinatal safety system that includes antenatal imaging, skilled examination, reliable referral pathways, and neonatal intensive care. Resources connected with the FAOPS 2020 archive reflect the wider scientific setting in which perinatal and neonatal teams exchange evidence about early detection, fetal development, and newborn care.

Why early detection matters

CCHD can involve inadequate pulmonary blood flow, obstruction of systemic blood flow, or mixing problems between oxygenated and deoxygenated blood. Newborns with these conditions may initially have normal color, feeding behavior, and respiratory effort. As transitional circulation changes, however, they can develop cyanosis, shock, metabolic acidosis, respiratory distress, or cardiovascular collapse.

Prenatal ultrasound can identify many major heart defects, but detection rates vary with maternal imaging access, fetal position, gestational age, equipment, and local expertise. A normal fetal scan therefore does not remove the need for newborn assessment. Pulse oximetry adds a postnatal checkpoint that can catch some defects missed before delivery.

The test is particularly valuable before discharge from a birth facility. Early recognition allows clinicians to arrange echocardiography, consult pediatric cardiology, begin prostaglandin therapy when indicated, and transfer the infant to an appropriate center. Timing can be decisive for lesions such as hypoplastic left heart syndrome, pulmonary atresia, critical coarctation of the aorta, and transposition of the great arteries.

How the screening test works

Screening is generally performed after the newborn is at least 24 hours old, or as late as possible before discharge if earlier discharge is unavoidable. Measuring too soon can produce false-positive results because normal cardiopulmonary transition is still occurring. The infant should be calm, warm, and free from movement that could interfere with the sensor.

A sensor is placed on the right hand to obtain a preductal reading and on either foot for a postductal reading. Many protocols consider a screen passed when both saturation values are at least 95% and the hand-foot difference is no more than 3 percentage points. Exact algorithms may differ by jurisdiction, so hospitals should follow an approved national or regional protocol rather than create informal thresholds.

A result below the accepted range does not automatically mean that CCHD is present. Lung disease, persistent pulmonary hypertension, infection, hypothermia, hemoglobin abnormalities, and other conditions can also reduce oxygen saturation. The newborn still needs prompt clinical evaluation, because a non-cardiac explanation can be serious and time-sensitive.

Maternal and fetal context should remain part of interpretation. Research on maternal stress and fetal development illustrates why neonatal assessment cannot be separated from the conditions surrounding pregnancy. A screening program should combine the number on the monitor with gestational history, delivery events, examination findings, and the infant’s overall stability.

Reading results and responding safely

A robust protocol separates a clear pass from an immediate referral and from a repeat-screen pathway. Borderline values may improve as transitional circulation settles, but repeated low readings should never be treated as a routine delay. Staff need a written algorithm that specifies who reviews the result, how quickly reassessment occurs, and when a medical escalation is mandatory.

The following framework summarizes a commonly used approach. Local guidance may use slightly different wording or timing, particularly for infants receiving respiratory support or those already admitted to intensive care.

The infant’s clinical condition overrides the screening pathway. A baby with central cyanosis, weak pulses, differential perfusion, severe tachypnea, lethargy, or poor feeding needs urgent assessment even if the recorded saturation briefly reaches a passing value. Conversely, a stable infant with a failed screen should be evaluated for both cardiac and non-cardiac causes of hypoxemia.

Documentation should include the infant’s age at testing, oxygen conditions, right-hand and foot values, repeat readings, symptoms, and the final disposition. Clear records help clinicians recognize deterioration, support quality audits, and prevent an abnormal result from being lost during transfer or discharge.

Limits and complementary assessments

Pulse oximetry screening detects many hypoxemic cardiac lesions, but it does not identify every serious congenital heart defect. Some infants with coarctation of the aorta, interrupted aortic arch, or certain left-sided obstructive lesions may maintain normal oxygen saturation until the circulation changes. A passing result therefore cannot replace pulse checks, cardiac examination, observation of feeding, and attention to perfusion.

False-positive results are possible, especially when testing occurs too early or in newborns with respiratory disease, infection, pulmonary hypertension, or other transitional problems. These results can increase parental anxiety and use of clinical resources. The answer is not to abandon screening, but to improve timing, staff training, equipment maintenance, and communication about what the result means.

False-negative results also require honest discussion. A normal reading does not rule out all congenital heart disease, and families should receive discharge advice about warning signs. Poor feeding, sweating during feeds, rapid breathing, blue or gray coloration, unusual sleepiness, and reduced urine output warrant immediate medical attention.

Genetic and family information may influence counseling when a congenital anomaly is identified. Discussions about recurrence risk, diagnostic testing, and future pregnancies should be sensitive and appropriately timed; clinicians can draw on developments in genetic counseling while keeping the immediate priority on stabilizing the newborn and explaining the next diagnostic step.

Building an effective hospital pathway

Successful screening depends less on the device alone than on the system around it. Every birth setting should identify who performs the test, where results are entered, which clinician receives alerts, and which hospital accepts a newborn needing echocardiography or specialist care. A screening policy without a dependable referral route can create false reassurance or dangerous delays.

Equipment should be approved for neonatal use and maintained according to the manufacturer’s instructions. Motion, poor sensor placement, low peripheral perfusion, ambient light, and an inadequate signal can distort readings. Staff competency programs should include hands-on practice, interpretation of preductal and postductal measurements, emergency escalation, and respectful communication with parents.

Hospitals should monitor process and outcome measures rather than focusing only on the number of failed screens. Useful indicators include screening completion before discharge, time from abnormal result to clinician review, repeat-screen compliance, transfer delays, false-positive rates, and CCHD cases detected after a negative screen. Reviewing missed cases can reveal gaps in prenatal imaging, examination, documentation, or follow-up.

Equity also matters. Rural facilities, low-resource hospitals, and communities with limited pediatric cardiology access may need tele-echocardiography, shared transport protocols, regional consultation, or mobile diagnostic services. A universal screening policy is most effective when families can reach the next level of care quickly and affordably.

Practical priorities for neonatal teams

Implementation should be simple enough for busy maternity units while retaining safeguards for unstable infants. Leadership support, clear accountability, and regular audit help convert a recommendation into a dependable clinical practice.

• Test newborns at the protocol-defined age, preferably after 24 hours and before discharge.
• Use the right hand and one foot, record both values, and verify a reliable signal before interpreting the result.
• Repeat borderline readings only within a clearly defined pathway, never as a substitute for evaluating a symptomatic infant.
• Ensure every failed screen receives timely medical review and access to echocardiography or specialist consultation.
• Explain to parents that screening reduces risk but does not exclude every heart defect, and provide clear warning signs for after discharge.

Parent communication should begin before the sensor is applied. Families can be told that the test is painless, takes only a few minutes, and looks for signs that the heart and lungs are delivering oxygen effectively. If the result is abnormal, staff should avoid describing it as a confirmed diagnosis while also avoiding false reassurance.

A coordinated team can make the process reassuring and clinically rigorous. Midwives, nurses, neonatologists, pediatric cardiologists, obstetric teams, primary care clinicians, transport services, and public health administrators all influence whether an abnormal result leads to timely treatment. The strongest programs treat screening as a connected pathway rather than an isolated measurement.

Hospitals and perinatal networks can act now by reviewing their screening policy, checking device accuracy, training every relevant staff group, and testing the referral pathway with a simulated abnormal result. Share the protocol with families and community clinicians, audit performance regularly, and update procedures as national guidance and local diagnostic capacity evolve.